Khalid Saad, Khatri Mahima, Siddiqui Mishal Shan, Ahmed Jawad
Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan.
Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan.
J Surg Res. 2022 Feb;270:252-260. doi: 10.1016/j.jss.2021.09.016. Epub 2021 Oct 26.
The effect of resuscitative endovascular balloon occlusion of aorta (REBOA) in lowering mortality rate compared to resuscitative thoracotomy (RT) is inconclusive. In this updated systematic review and meta-analysis, we determined the effectiveness of the two techniques in patients with noncompressible torso hemorrhage (NCTH).
Online databases (PubMed, Embase, and MEDLINE) were searched until April 23, 2021, for original articles investigating the effect of REBOA on relevant outcomes (e.g., mortality in ED, mortality before discharge, in-hospital mortality, length of hospital stay and length of ICU stay) among NCTH patients in contrast to open aortic occlusion by RT. Data on baseline characteristics and endpoints were extracted. Review Manager version 5.4.1 and OpenMetaAnalyst were used for analyses. Risk ratios (RR) and the weighted mean differences (WMD) with corresponding 95% confidence intervals were calculated.
Eight studies were included having 3241 patients in total (REBOA: 1179 and RT: 2062). The pooled analysis demonstrated that compared to RT, mortality was significantly lower in the REBOA group in all settings: In emergency department (ED) (RR 0.63 [0.45, 0.87], P = 0.006, I = 81%), before discharge (RR= 0.86 [0.75, 0.98], P = 0.03, I 93%), and in-hospital mortality (RR 0.80 [0.68, 0.95], P = 0.009, I 85%). Similarly, the length of ICU stay was significantly lower in REBOA group (WMD = 0.50 [-0.48, 1.48], P = 0.32, I97%). However, no significant differences were observed in the length of hospital stay (WMD = 0.0 [-0.26, 0.26] P = 1).
Our pooled analysis shows REBOA to be effective in reducing mortality among NCTH patients. However, due to limited studies, the positive findings should be viewed discreetly and call for further investigation.
与开胸复苏术(RT)相比,复苏性血管内主动脉球囊阻断术(REBOA)在降低死亡率方面的效果尚无定论。在这项更新的系统评价和荟萃分析中,我们确定了这两种技术在不可压缩性躯干出血(NCTH)患者中的有效性。
检索在线数据库(PubMed、Embase和MEDLINE)直至2021年4月23日,以查找研究REBOA对NCTH患者相关结局(如急诊科死亡率、出院前死亡率、住院死亡率、住院时间和重症监护病房住院时间)影响的原始文章,并与RT进行开放性主动脉阻断对比。提取基线特征和终点数据。使用Review Manager 5.4.1版和OpenMetaAnalyst进行分析。计算风险比(RR)和加权平均差(WMD)以及相应的95%置信区间。
纳入八项研究,共3241例患者(REBOA组:共1179例;RT组:共2062例)。汇总分析表明,与RT相比,REBOA组在所有情况下死亡率均显著降低:在急诊科(RR 0.63 [0.45, 0.87],P = 0.006,I² = 81%)、出院前(RR = 0.86 [0.75, 0.98],P = 0.03,I² = 93%)和住院死亡率(RR 0.80 [0.68, 0.95],P = 0.009,I² = 85%)。同样,REBOA组的重症监护病房住院时间显著缩短(WMD = 0.50 [-0.48, 1.48],P = 0.32,I² = 97%)。然而,住院时间未观察到显著差异(WMD = 0.0 [-0.26, 0.26],P = 1)。
我们的汇总分析表明REBOA在降低NCTH患者死亡率方面有效。然而,由于研究有限,这些阳性结果应谨慎看待,需要进一步研究。